I don't know -- just because it works on one cancer in the first trial to report results, that doesn't mean that the stock isn't bad and that it isn't going to go to zero. This is bad news, give me some time and I'll find some way to say it's bad that Kevetrin works.

**SARCASM BUTTON OFF**